Adam Taich, Chief Financial Officer at 10x Genomics, Inc. (TXG), sold 46,388 shares at $63.68 ($3.0M) on 2026-09-09, disclosed to the SEC on 2026-09-11.
Scheduled sale ($3.0M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $63.68 | 1,206 | $77K | 2.6% |
| 2 | $64.31 | 31,428 | $2.0M | 67.5% |
| 3 | $65.26 | 13,754 | $898K | 30.0% |
| Total | $64.57 avg | 46,388 | $3.0M | 100% |
| Filing → |
| TXG | SELL | 2026-02-25 | $167K | — | Filing → |
| TXG | SELL | 2025-11-25 | $226K | — | Filing → |
| TXG | SELL | 2025-08-26 | $615K | — | Filing → |